Marjaana Viljanto
Re-evaluation of the regulation of omeprazole in racehorses: an evidence-based approach
Viljanto, Marjaana; Hillyer, Lynn; Hincks, Pamela; Pearce, Clive; Paine, Stuart
Authors
Lynn Hillyer
Pamela Hincks
Clive Pearce
STUART PAINE Stuart.Paine@nottingham.ac.uk
Professor of Pharmacometrics
Abstract
Medication and doping control has been established in horseracing to ensure the integrity of the sport and the welfare of the horses. This ensures that horses do not compete under the influence of any drugs, including omeprazole, a therapeutic medication used to treat equine gastric ulcer syndrome. In this study, pharmacokinetic data were produced in equine plasma and urine following an oral administration of 4 mg/kg of generic buffered formulation of omeprazole to six Thoroughbred horses in five daily doses to determine an appropriate screening limit and detection time in equine plasma and to assess whether the current detection time of 72 hours in equine urine would be applicable when an alternative omeprazole product is administered. Cmax of 436 – 2432 ng/mL and AUC0-tau of 1476 – 4371 ng.hr/mL were obtained for plasma and indicated, in conjunction with other published oral omeprazole studies, that an appropriate plasma screening limit would be 500 pg/mL with a detection time of 48 hours. Urine analysis showed that omeprazole could be detected for up to 25 hours above the previously established urine screening limit of 500 pg/mL, and thus, indicated that the detection time advice could be potentially reduced from 72 hours to 48 hours to allow more comprehensive treatment of gastric lesions.
Citation
Viljanto, M., Hillyer, L., Hincks, P., Pearce, C., & Paine, S. (2018). Re-evaluation of the regulation of omeprazole in racehorses: an evidence-based approach. Journal of Veterinary Pharmacology and Therapeutics, 41(3), 469-475. https://doi.org/10.1111/jvp.12491
Journal Article Type | Article |
---|---|
Acceptance Date | Jan 11, 2018 |
Online Publication Date | Feb 22, 2018 |
Publication Date | Jun 1, 2018 |
Deposit Date | Apr 17, 2018 |
Publicly Available Date | Mar 29, 2024 |
Journal | Journal of Veterinary Pharmacology and Therapeutics |
Print ISSN | 0140-7783 |
Electronic ISSN | 1365-2885 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 41 |
Issue | 3 |
Pages | 469-475 |
DOI | https://doi.org/10.1111/jvp.12491 |
Keywords | detection time; medication control; omeprazole; pharmacokinetics; screening limit |
Public URL | https://nottingham-repository.worktribe.com/output/961507 |
Publisher URL | https://onlinelibrary.wiley.com/doi/abs/10.1111/jvp.12491 |
Additional Information | This is the peer reviewed version of the following article: Viljanto M, Hillyer L, Hincks P, Pearce C, Paine SW. Re-evaluation of the regulation of omeprazole in racehorses: An evidence-based approach. J vet Pharmacol Therap. 2018; 41,3:469-497. https://doi.org/10.1111/jvp.12491, which has been published in final form at https:/doi.org/10.1111/jvp.12491. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. |
Files
Omeprazole paper.pdf
(743 Kb)
PDF
You might also like
Plasma and urine pharmacokinetics of two formulations of dexamethasone in greyhound dogs
(2021)
Journal Article
Pharmacokinetics of carprofen and firocoxib for medication control in racing greyhounds
(2020)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: digital-library-support@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search